Plans for communicating important protocol amendments to relevant parties (e.g. trial participants, ethical committees) {25}
Important changes in this protocol will be reported to the National Ethical Review Board, Sweden, and an amendment approval will be sought. Further, important changes will be registered in ClinicalTrials.gov and communicated to the site investigators, research nurses and monitors by established networks.